A02057 Summary:

BILL NOA02057
 
SAME ASNo Same As
 
SPONSORMayer
 
COSPNSR
 
MLTSPNSR
 
Amd §230, Pub Health L
 
Provides that the director of the office of professional medical conduct shall meet with complainants, when requested by the complainant, to review materials to be considered by the board for professional medical conduct when considering complaints of misconduct.
Go to top    

A02057 Actions:

BILL NOA02057
 
01/17/2017referred to health
01/03/2018referred to health
04/30/2018enacting clause stricken
Go to top

A02057 Committee Votes:

Go to top

A02057 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A02057 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          2057
 
                               2017-2018 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 17, 2017
                                       ___________
 
        Introduced  by M. of A. MAYER -- read once and referred to the Committee
          on Health
 
        AN ACT to amend the public health law, in relation to investigations  of
          professional medical conduct
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subparagraph (i) of paragraph  (a)  of  subdivision  10  of
     2  section  230  of  the public health law, as amended by chapter 11 of the
     3  laws of 2015, is amended to read as follows:
     4    (i) (A) The board for professional medical conduct, by the director of
     5  the office of professional medical conduct, may investigate on  its  own
     6  any  suspected  professional  misconduct,  and  shall  investigate  each
     7  complaint received regardless of the source.  The director of the office
     8  of professional medical conduct, when requested by a complainant,  shall
     9  meet  with  the  complainant to review materials to be considered by the
    10  board in its review of suspected professional medical misconduct. By the
    11  conclusion of a  preliminary  review,  including  an  internal  clinical
    12  review,  the  director  shall determine if a report is based solely upon
    13  the recommendation or provision of a treatment modality  by  a  licensee
    14  that  is  not  universally accepted by the medical profession, including
    15  but not limited to varying modalities used  in  the  treatment  of  Lyme
    16  disease or other tick-borne diseases. Upon a determination by the direc-
    17  tor  that  a  report  is  based solely upon the provision of a treatment
    18  modality that is not universally accepted, no further  review  shall  be
    19  conducted and no charges shall be brought. Nothing in this section shall
    20  preclude  the  director  from making such a determination earlier in, or
    21  subsequent to, a preliminary review. (B) The director of the  office  of
    22  professional  medical  conduct shall cause a preliminary review of every
    23  report made to the department pursuant to section  twenty-eight  hundred
    24  three-e as added by chapter eight hundred sixty-six of the laws of nine-
    25  teen hundred eighty, sections twenty-eight hundred five-l and forty-four
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02500-01-7

        A. 2057                             2
 
     1  hundred five-b of this chapter, and section three hundred fifteen of the
     2  insurance law, to determine if such report reasonably appears to reflect
     3  physician  conduct  warranting  further  investigation  pursuant to this
     4  subparagraph.
     5    §  2.  Paragraph  (e)  of  subdivision 10 of section 230 of the public
     6  health law, as amended by chapter 606 of the laws of 1991, is amended to
     7  read as follows:
     8    (e) Committee hearing. The hearing shall be conducted by  a  committee
     9  on professional conduct.  At least twenty-five percent of such committee
    10  shall  be  non-medical  personnel.  The members of the hearing committee
    11  shall be appointed by the chairperson of the board who  shall  designate
    12  the  committee  chairperson.  In addition to said committee members, the
    13  commissioner shall designate  an  administrative  officer,  admitted  to
    14  practice  as  an  attorney  in the state of New York, who shall have the
    15  authority to rule on all motions, including motions to compel disclosure
    16  of information or material claimed to be protected because of  privilege
    17  or  confidentiality,  procedures  and  other  legal objections and shall
    18  draft the conclusions of the hearing committee pursuant to paragraph (g)
    19  of this subdivision.  The administrative officer shall have the authori-
    20  ty to rule on objections to questions  posed  by  either  party  or  the
    21  committee  members.  The administrative officer shall not be entitled to
    22  vote.
    23    § 3. This act shall take effect on the sixtieth  day  after  it  shall
    24  have  become  a law. Provided, that effective immediately, the addition,
    25  amendment and/or repeal of any rule  or  regulation  necessary  for  the
    26  implementation  of  this  act  on  its effective date are authorized and
    27  directed to be made and completed by the commissioner of  health  on  or
    28  before  such  effective date; and provided, further, that the amendments
    29  to subparagraph (i) of paragraph (a) of subdivision 10 of section 230 of
    30  the public health law made by section one of this act shall  not  affect
    31  the  expiration  of  such paragraph and shall be deemed to expire there-
    32  with.
Go to top